Alma Bio Therapeutics will present at the French-Israeli joint healthcare event in Paris

December 2019 – Alma Bio Therapeutics will be attending the French-Israeli joint event in the healthcare sector, Paris December 10, 2019, sponsored by the BPI, the French Public Investment Bank. As part of the BPI’s ongoing strive to attract international investors, senior BPI executives and French and Israeli VCs, will explore the opportunities for joint collaboration between the two countries.

Dr. Binah Baum, Alma’s CEO and cofounder, has been invited to present the company in front of a distinguished audience of investors, executives and conference attendees.